Management of Symptomatic Hypotension

Assessment and Diagnosis

The European Society of Cardiology recommends focusing on assessing organ perfusion and correlating symptoms with documented low blood pressure rather than treating blood pressure numbers alone, as symptomatic hypotension requires immediate evaluation to determine if the patient needs urgent intervention or can be managed with targeted therapy based on the underlying cause 1, 2
The American Heart Association suggests determining hemodynamic stability first by assessing whether the patient has signs of end-organ hypoperfusion, such as altered mental status, cool extremities, decreased urine output, and elevated lactate, rather than focusing solely on the blood pressure number 3, 2
A systolic BP <80 mmHg warrants immediate attention and potential treatment adjustment, according to the European Journal of Heart Failure 4, 1, 5
Symptomatic hypotension at any blood pressure level requires evaluation if symptoms correlate with documented low readings, as stated by the European Journal of Heart Failure 1

The American College of Cardiology recommends immediately evaluating for signs of inadequate perfusion, including obtaining serum lactate and arterial blood gas as markers of tissue perfusion, performing bedside echocardiography to evaluate cardiac function and volume status, monitoring urine output, mental status, and skin perfusion, and obtaining a 12-lead ECG to identify arrhythmias 2
If poor organ perfusion is present, such as cardiogenic shock or severe hypoperfusion, this requires hospitalization and potentially inotropic support, according to the European Journal of Heart Failure and Circulation 4, 3, 1

The European Society of Cardiology suggests systematically addressing reversible causes, including dehydration, acute blood loss or anemia, infection/sepsis, and medication review, before initiating specific hypotension treatment 4, 1, 2
The American Heart Association recommends reviewing and discontinuing or reducing medications that lower blood pressure unnecessarily, such as diuretics, alpha-blockers, vasodilators, and antihypertensives, as stated by Circulation 3

In patients with heart failure and reduced ejection fraction, asymptomatic or mildly symptomatic low BP should not prevent guideline-directed medical therapy, according to the European Journal of Heart Failure 1, 5
Only major symptoms or SBP <80 mmHg warrant guideline-directed medical therapy adjustment, as stated by the European Journal of Heart Failure 4, 1

The American College of Cardiology recommends initiating non-pharmacologic measures, such as increasing fluid intake, increasing salt intake, elevating the head of the bed, using compression stockings, and performing physical counterpressure maneuvers, before considering medications 5
If non-pharmacologic measures fail and symptoms significantly impair quality of life, pharmacotherapy may be initiated, according to Praxis Medical Insights 5

Midodrine is an FDA-approved medication for orthostatic hypotension, and the dosage should be started at 2.5-5 mg three times daily, with a maximum dose of 10 mg three times daily, as stated by Praxis Medical Insights 5
Droxidopa is an FDA-approved alternative, with a starting dose of 100 mg three times daily, titrated up to 600 mg three times daily, according to Praxis Medical Insights 5

If a patient presents with symptomatic hypotension and signs of low cardiac output, correction of volume depletion should be done first, followed by consideration of intravenous inotropes, such as dobutamine or milrinone, if severe systolic dysfunction with low output syndrome is present, as stated by Circulation 3

For patients with severe symptomatic hypotension requiring intervention, continuous ECG, blood pressure, and oxygen saturation monitoring for at least 24 hours, serial lactate measurements, strict intake/output monitoring, and daily weights are recommended, according to Praxis Medical Insights 2